CD8A and non-small cell lung carcinoma: For example, Parra et al. (2023) used a 23-marker tumour immunoprofiling panel on NSCLC tumour cells, and reported that CD3+ CD8+ cytotoxic T-cells were the most abundant immune cells in both adenocarcinoma and squamous cell carcinoma, but were relatively distant from malignant cells.